Etavopivat/ FT-4202

Hello,
Doctors here at Oakland Children's Hospital are wanting to enroll child for Etavopivat clinical trials to increase Hg by 1.5 points, hence increasing the gap between transfusions.

It's  a clinical trial, more trips to hospital, and more MRI scans needed, so thinking about it.

Does anyone have any experience with it or inputs?

Thanks

Have the doctors given you any information about how well it is working in patients already in the trial? I was also curious whether or not Luspatercept, Reblozyl has been tried yet.